Veloxis Pharmaceuticals AS:企業の戦略的SWOT分析

◆英語タイトル:Veloxis Pharmaceuticals AS - Strategic SWOT Analysis Review
◆商品コード:GDPH61177SA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Veloxis Pharmaceuticals AS – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Veloxis Pharmaceuticals A/S (Veloxis), a subsidiary of Asahi Kasei Corp, is a specialty pharmaceutical company that identifies, develops and commercializes pharmaceutical drugs in transplantation and adjacent therapies. The company lead product is ENVARSUS XR (tacrolimus extended-release tablets) for the prophylaxis of organ rejection in kidney transplant patients. ENVARSUS is developed based on the company’s proprietary, patented drug delivery technology, MeltDose, which is designed to enhance the absorption and bioavailability of select orally administered drugs. The company sells ENVARSUS XR to government agencies, specialty pharmacies, managed healthcare organizations, wholesalers and retail customers across the US, Europe and worldwide. Veloxis is headquartered in Copenhagen, Denmark.

Veloxis Pharmaceuticals AS Key Recent Developments

Jan 29,2020: Nasdaq Copenhagen has accepted Veloxis Pharmaceuticals request for Delisting of its Shares from Nasdaq Copenhagen
Nov 26,2019: Asahi Kasei offers to buy Veloxis Pharmaceuticals for $1.3bn
Nov 12,2019: Veloxis Pharmaceuticals announces financial results for the first nine months of 2019
Aug 08,2019: Veloxis Pharmaceuticals announces financial results for the first six months of 2019
Jul 22,2019: Veloxis revises outlook for 2019 based on strong performance

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Veloxis Pharmaceuticals AS – Key Facts
Veloxis Pharmaceuticals AS – Key Employees
Veloxis Pharmaceuticals AS – Key Employee Biographies
Veloxis Pharmaceuticals AS – Major Products and Services
Veloxis Pharmaceuticals AS – History
Veloxis Pharmaceuticals AS – Company Statement
Veloxis Pharmaceuticals AS – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Veloxis Pharmaceuticals AS – Business Description
Veloxis Pharmaceuticals AS – SWOT Analysis
SWOT Analysis – Overview
Veloxis Pharmaceuticals AS – Strengths
Veloxis Pharmaceuticals AS – Weaknesses
Veloxis Pharmaceuticals AS – Opportunities
Veloxis Pharmaceuticals AS – Threats
Veloxis Pharmaceuticals AS – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Veloxis Pharmaceuticals AS, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Veloxis Pharmaceuticals AS, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Veloxis Pharmaceuticals AS, Recent Deals Summary
Section 4 – Company’s Recent Developments
Jan 29, 2020: Nasdaq Copenhagen has accepted Veloxis Pharmaceuticals request for Delisting of its Shares from Nasdaq Copenhagen
Nov 26, 2019: Asahi Kasei offers to buy Veloxis Pharmaceuticals for $1.3bn
Nov 12, 2019: Veloxis Pharmaceuticals announces financial results for the first nine months of 2019
Aug 08, 2019: Veloxis Pharmaceuticals announces financial results for the first six months of 2019
Jul 22, 2019: Veloxis revises outlook for 2019 based on strong performance
May 06, 2019: Veloxis Pharmaceuticals announces financial results for the first three months of 2019
Feb 27, 2019: Veloxis Pharmaceuticals releases annual report for 2018
Jan 03, 2019: Mark Hensley promoted to Chief Commercial Officer of Veloxis Pharmaceuticals
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Veloxis Pharmaceuticals AS, Key Facts
Veloxis Pharmaceuticals AS, Key Employees
Veloxis Pharmaceuticals AS, Key Employee Biographies
Veloxis Pharmaceuticals AS, Major Products and Services
Veloxis Pharmaceuticals AS, History
Veloxis Pharmaceuticals AS, Subsidiaries
Veloxis Pharmaceuticals AS, Key Competitors
Veloxis Pharmaceuticals AS, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Veloxis Pharmaceuticals AS, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Veloxis Pharmaceuticals AS, Recent Deals Summary

★海外企業調査レポート[Veloxis Pharmaceuticals AS:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Brother Enterprises Holding Co., Ltd.:企業の戦略・SWOT・財務情報
    Brother Enterprises Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Brother Enterprises Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Tata Power Solar Systems Ltd:企業の戦略的SWOT分析
    Tata Power Solar Systems Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • TauRx Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary TauRx Pharmaceuticals Ltd (TauRx) discovers, develops and commercializes treatments and diagnostics for Alzheimer's disease and other neurodegenerative diseases. Its pipeline products include LMTX, a tau aggregation inhibitor (TAI) for Alzheimer’s and Behavioural variant frontotemporal demen …
  • Kimball International, Inc. (KBAL):企業の財務・戦略的SWOT分析
    Kimball International, Inc. (KBAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • SPI Pharma Inc:企業の戦略的SWOT分析
    SPI Pharma Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Nila Infrastructures Ltd:企業の戦略・SWOT・財務情報
    Nila Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report Summary Nila Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Wentworth Resources Ltd (WRL)-石油・ガス分野:企業M&A・提携分析
    Summary Wentworth Resources Limited (Wentworth) is an independent upstream oil and gas company. It conducts the exploration and development of oil and natural gas reserves. The company has producing gas assets in Tanzania, oil and gas exploration activities in both Mozambique and Tanzania. The compa …
  • Penn Virginia Corporation (PVAC)-石油・ガス分野:企業M&A・提携分析
    Summary Penn Virginia Corporation (Penn Virginia) is an independent oil and gas company. It explores, develops, and produces crude oil, Natural gas liquids (NGL), and natural gas. The company carries out its operations in various domestic onshore regions of the US, primarily in the Eagle Ford Shale …
  • Key Energy Services Inc (KEG):石油・ガス:M&Aディール及び事業提携情報
    Summary Key Energy Services Inc (Key) is an onshore, rig-based well servicing contractor, which offers a range of rig services. Its service line includes rig-based and coiled tubing-based well maintenance and workover services, well completion and recompletion services, fluid management services, fi …
  • Ashtead Group Plc (AHT):企業の財務・戦略的SWOT分析
    Ashtead Group Plc (AHT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Otrum AS:企業の戦略的SWOT分析
    Otrum AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Quadra – Power Generation:企業の発電所・SWOT分析2018
    Quadra - Power Generation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Macy’s Inc:戦略・SWOT・企業財務分析
    Macy's Inc - Strategy, SWOT and Corporate Finance Report Summary Macy's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Petroleo Brasileiro SA:企業の戦略・SWOT・財務分析
    Petroleo Brasileiro SA - Strategy, SWOT and Corporate Finance Report Summary Petroleo Brasileiro SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Group Five Limited (GRF):企業の財務・戦略的SWOT分析
    Group Five Limited (GRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Lamprell Plc (LAM):企業の財務・戦略的SWOT分析
    Lamprell Plc (LAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • GE Healthcare:企業の戦略・SWOT・財務分析
    GE Healthcare - Strategy, SWOT and Corporate Finance Report Summary GE Healthcare - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Kao Corp (4452):企業の財務・戦略的SWOT分析
    Kao Corp (4452) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Absorption Systems LP-医療機器分野:企業M&A・提携分析
    Summary Absorption Systems LP (Absorption Systems) is a pre-clinical contract research organization that develops and implements research tools. The organization carries out preclinical testing of drugs, biologics, and medical devices. It develops and implements research tools to predict human outco …
  • NTPC Ltd (NTPC):石油・ガス:M&Aディール及び事業提携情報
    Summary NTPC Ltd (NTPC) is a Public sector undertaking energy conglomerate. It has presence in the entire value chain of the power generation business. The company produces electricity and sells that to state power utilities on wholesale basis. NTPC generates power using coal, gas, liquid fuel and h …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆